These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 14514380

  • 1. [Comparison of the Epstein-Barr virus infection and 30 bp-deleted LMP1 gene among 4 histologic types of nasopharyngeal carcinoma].
    Zhang M, Zong YS, He JH, Zhong BL, Lin SX, Liang YJ.
    Zhonghua Bing Li Xue Za Zhi; 2003 Aug; 32(4):342-6. PubMed ID: 14514380
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL, Zong YS, Lin SX, Zhang M, Liang YJ.
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [Abstract] [Full Text] [Related]

  • 3. [Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma].
    Lin SX, Zong YS, Zhang M, Han AJ, Zhong BL, Liang YJ.
    Zhonghua Bing Li Xue Za Zhi; 2005 Dec; 34(12):791-5. PubMed ID: 16545188
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Loss of an XhoI-site within N-terminal region of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma.
    Lin SX, Zong YS, Wu QL, Han AJ, Liang YJ.
    Ai Zheng; 2003 Nov; 22(11):1147-51. PubMed ID: 14613641
    [Abstract] [Full Text] [Related]

  • 6. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais.
    Tiwawech D, Srivatanakul P, Karalak A, Ishida T.
    J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201
    [Abstract] [Full Text] [Related]

  • 7. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK, Lee BY, Kim JE, Lee SS, Kim CW.
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [Abstract] [Full Text] [Related]

  • 8. [Primary adenoid cystic carcinoma of the nasopharynx and its relation to Epstein-Barr virus infection].
    He JH, Zong YS, Zhang M, Zhong BL, Liang YJ, Liang XM.
    Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):234-7. PubMed ID: 12882689
    [Abstract] [Full Text] [Related]

  • 9. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K, Chen WG, Chen YY, Murakami I, Chen HL, Ohara N, Nose S, Hamaya K, Matsui S, Bacchi MM, Bacchi CE, Chang KL, Weiss LM.
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA, Zekri AR, Asaad N, El-Houssini S, Khalid HM, Sedky LM, Mokhtar NM.
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [Abstract] [Full Text] [Related]

  • 11. Characterization of Epstein-Barr virus strains and LMP1-deletion variants in Portugal.
    Neves M, Marinho-Dias J, Ribeiro J, Esteves M, Maltez E, Baldaque I, Breda E, Monteiro E, Medeiros R, Sousa H.
    J Med Virol; 2015 Aug; 87(8):1382-8. PubMed ID: 25879824
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S, Yoshizaki T, Park CS, Furukawa M.
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [Abstract] [Full Text] [Related]

  • 14. Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients.
    Hadhri-Guiga B, Khabir AM, Mokdad-Gargouri R, Ghorbel AM, Drira M, Daoud J, Frikha M, Jlidi R, Gargouri A.
    Virus Res; 2006 Jan; 115(1):24-30. PubMed ID: 16154221
    [Abstract] [Full Text] [Related]

  • 15. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF, Wu QL, Zong YS.
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia.
    See HS, Yap YY, Yip WK, Seow HF.
    World J Surg Oncol; 2008 Feb 15; 6():18. PubMed ID: 18275617
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Detection of Epstein-Barr virus in nasopharyngeal carcinoma by in situ hybridization and polymerase chain reaction.
    Murono S, Yoshizaki T, Tanaka S, Takeshita H, Park CS, Furukawa M.
    Laryngoscope; 1997 Apr 15; 107(4):523-6. PubMed ID: 9111384
    [Abstract] [Full Text] [Related]

  • 20. The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies.
    da Costa VG, Marques-Silva AC, Moreli ML.
    Syst Rev; 2015 Apr 13; 4():46. PubMed ID: 25927427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.